Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
KAPA
KAPA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
KAPA News
Kairos Pharma Wins 2025 Clinical Trials Arena R&D Award for Advanced Prostate Cancer
Dec 17 2025
Businesswire
D. Boral Capital Reiterates Buy Rating on Kairos Pharma with $9 Price Target Intact
Nov 04 2025
Benzinga
D. Boral Capital Upholds Buy Rating for Kairos Pharma (KAPA)
Oct 21 2025
NASDAQ.COM
Kairos Pharma Discusses Phase 2 Trial Results of ENV-105 for Advanced Prostate Cancer at ESMO Conference
Oct 20 2025
Newsfilter
D. Boral Capital Reiterates Buy Rating on Kairos Pharma with $9 Price Target Intact
Oct 07 2025
Benzinga
FedEx Shares Rise 5%; Check Out 20 Stocks Making Moves in Premarket Trading
Sep 19 2025
Benzinga
Kairos Pharma to Host Virtual KOL Event Discussing Interim Efficacy Results of ENV105 in Advanced Prostate Cancer
Sep 11 2025
Newsfilter
Carisma Therapeutics Shares Surge 133%; Check Out 20 Stocks Making Moves in Premarket Trading
Sep 02 2025
Benzinga
5 Biotech Stocks to Monitor Before Key Clinical Trial Results in September 2025
Aug 27 2025
NASDAQ.COM
Why Data Storage Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket
Jul 16 2025
Benzinga
Why Is Kairos Pharma Stock Surging On Tuesday?
Jul 15 2025
Benzinga
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
Jul 15 2025
TipRanks
Nasdaq Gains Over 100 Points; Wells Fargo Earnings Top Views
Jul 15 2025
Benzinga
Kairos Pharma Stock Soars After Positive Interim Results From Phase 2 Trial Of ENV-105
Jul 15 2025
NASDAQ.COM
Dow Falls Over 100 Points; JPMorgan Posts Upbeat Earnings
Jul 15 2025
Benzinga
Why Is Kairos Pharma Stock (KAPA) Up 170% Today?
Jul 15 2025
TipRanks
Show More News
